Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen C

Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities

Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Gerald Commissiong , John Commissiong , Donald Huffman , Contract Research Organization , Cutanogen Corporation , Elto Pharma Inc , Amarantus Bioscience Holdings , Company Acting , Group Of The Company , Lonza Group , Todos Medical Ltd , Therapeutics Inc , Amarantus Bioscience Holdings Inc , Company Engineered Skin Substitute , Engineered Skin Substitute , Elto Pharma , Term Sheet , Todos Medical , Next Step , Range Finding , Astrocyte Derived Neurotrophic Factor , Vision Loss , Bioscience Holdings , Retinitis Pigmentosa , Chief Scientific Officer John Commissiong , Media Contact , United States Wire Group ,